Tarasaponin VI

CAS No. 59252-95-8

Tarasaponin VI( —— )

Catalog No. M26473 CAS No. 59252-95-8

Tarasaponin VI is isolated from Aralia elata with potent inhibitory activity on ethanol absorption.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 412 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tarasaponin VI
  • Note
    Research use only, not for human use.
  • Brief Description
    Tarasaponin VI is isolated from Aralia elata with potent inhibitory activity on ethanol absorption.
  • Description
    Tarasaponin VI is isolated from Aralia elata with potent inhibitory activity on ethanol absorption.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PD-1/PD-L1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    59252-95-8
  • Formula Weight
    764.95
  • Molecular Formula
    C41H64O13
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (130.73 mM)
  • SMILES
    [H][C@@]1(O[C@H]2[C@H](O)[C@@H](O)[C@]([H])(O[C@H]3CC[C@@]4(C)[C@@]([H])(CC[C@]5(C)[C@]4([H])CC=C4[C@]6([H])CC(C)(C)CC[C@@]6(CC[C@@]54C)C(O)=O)C3(C)C)O[C@@H]2C(O)=O)O[C@@H](CO)[C@H](O)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gaudy-Marqueste C, Dussouil AS, Carron R, Troin L, Malissen N, Loundou A, Monestier S, Mallet S, Richard MA, Régis JM, Grob JJ. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery. Eur J Cancer. 2017 Oct;84:44-54.
molnova catalog
related products
  • (1S,4R)-N-Desmethyl ...

    (1S,4R)-N-Desmethyl Sertraline Hydrochloride is a chemical compound.

  • [Pyr1]-Apelin-13

    [Pyr1]-Apelin-13 is a potent and selective endogenous Apelin receptor (APJ) agonist.[Pyr1]-apelin-13 encapsulation in lipoPEG particles (lipoPEG-PA13) results in sustained and extended drug release under physiological conditions[1].[Pyr1]-apelin-13 nanocarriers in a mouse model of pressure-overload induced heart failure demonstrate a sustainable long-term effect of [Pyr1]-apelin-13 in preventing cardiac dysfunction.

  • DS-2330

    DS-2330 is a phosphorous lowering agent for treating hyperphosphatemia in chronic kidney disease.